Persistent Dyspnea in COVID-19 Survivors without Structural Cardiopulmonary Disease: Multidimensional Phenotyping at 4 Years.

Publication date: May 20, 2026

Persistent dyspnea despite normal cardiopulmonary structure is a frequent but poorly understood long-term sequela of COVID-19. Scant data exist on the multidimensional clinical profiles that underlie dyspnea in this setting. We aimed to characterize multidimensional phenotypes associated with persistent dyspnea several years after COVID-19 hospitalization. Post-hospitalization COVID-19 survivors without structural cardiopulmonary disease underwent assessment 41-47 months after acute infection, including respiratory muscle strength, diaphragm and parasternal intercostal ultrasound, exercise capacity, peripheral muscle evaluation, and patient-reported outcomes. Predefined univariate analyses examined associations with persistent dyspnea (mMRC ≥ 2) and inspiratory muscle weakness (MIP and SNIP 

Concepts Keywords
47months COVID-19 survivors
Cardiopulmonary Diaphragm ultrasound
Hospitalization Inspiratory muscle weakness
Poorly Multidimensional phenotyping
Predefined Persistent dyspnea

Semantics

Type Source Name
disease MESH Dyspnea
disease MESH COVID-19
disease MESH infection
disease MESH muscle weakness
disease MESH MIP
disease MESH Long Covid

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *